Skip to Content


Gus Ruelas—Reuters
  • Previous Rank29
  • Revenues ($M)$92,105.0
  • Revenue Percent Change2.3%
  • Profits ($M)$3,750.0
  • Profits Percent Change-2.4%
  • Assets ($M)$71,571.0
  • Employees63,900

Health care companies are in a rush to consolidate vertically so they can control as many links in the medical supply chain as possible (see: the mammoth CVS-Aetna deal which married a retail prescription giant with a major insurer). Anthem, which is the largest for-profit component of the sprawling Blue Cross and Blue Shield insurance federation, is no different. In its 2018 full-year earnings report, Anthem CEO Gail Boudreaux emphasized the firm’s launch of its own pharmacy benefits manager following its decision last year to end a relationship with Express Scripts, which became a part of Anthem rival Cigna at the end last year. While the company’s decision to exit several Affordable Care Act markets hurt its overall membership numbers, growth in its Medicare and Medicaid managed care businesses helped offset the losses. Anthem’s full-year operating revenues increased modestly to $91.3 billion in 2018.

Fortune Data StoreLooking for leads, investment insights, or competitive intelligence?Get Premium Access

Company Info

Gail K. Boudreaux
CEO Title
President, Chief Executive Officer & Director
Health Care
Health Care: Insurance and Managed Care
HQ Location
Indianapolis, Ind.
Years on Fortune 500 List25

Anthem Rank History

Key Financials (Last Fiscal Year)

$ millions% change
Revenues ($M)$92,105.02.3%
Profits ($M)$3,750.0-2.4%
Assets ($M)$71,571.0-
Total Stockholder Equity ($M)$28,541.0-

Profit Ratios

Profit as % of Revenues4.1%
Profits as % of Assets5.2%
Profits as % of Stockholder Equity13.1%

Earnings Per Share (Last Fiscal Year)

Earnings Per Share ($)14.19
EPS % Change (from 2017)-1.1%
EPS % Change (5 year annual rate)11.6%
EPS % Change (10 year annual rate)11.5%

Total Return

Total Return to Investors (2018)18.2%
Total Return to Investors (5 year, annualized)25.2%
Total Return to Investors (10 year, annualized)21.6%